Good afternoon. Welcome to Amprius Technologies presentation of its third quarter 2022 earnings call. My name is Ryan, and I will be your operator this afternoon. Joining us for today's presentation are the company's CEO, Dr. Kang Sun; and CFO, Sandra Wallach. Following management's remarks, we will open the call for questions. Please note that this presentation contains forward-looking statements. These statements are based on Amprius Technology business and expected market opportunities and are subject to uncertainty and changes in circumstances, many of which are beyond Amprius' control, which may cause actual results to differ materially from those expressed or implied in such forward-looking statements. For a more complete discussion on forward-looking statements and the uncertainties related to Amprius Technologies' business and expected market opportunities, please refer to its filing with the Securities and Exchange Commission, including the discussion of Amprius risk factors in its 8-K filed on September 16, 2022. I will now turn the call over to CEO, Dr. Kang Sun, for his comments. Sir, please proceed.

Good afternoon, everyone, and thank you for joining us today for Amprius' inaugural earnings call. Today is an important milestone for Amprius, and we are so glad that you could join us for our first quarterly earnings call as a public company. Today, we will discuss our third quarter financial results, key business drivers and the step we are taking to advance our strategic plan for high-volume production of our silicon nanowire anode batteries. For those new to the Amprius story, I'd like to begin today's call by providing some background on who we are. Amprius was founded in 2008 to commercialize the silicon nanowire anode concept that was originally developed at Stanford University. In 2014, we finalized our silicon nanowire anode structure design and its manufacturing process. In 2016, we built our first kilowatt-hour scale manufacturing line in California. Two years later, Amprius received its first purchase order from Airbus and began its journey towards commercialization. Last year, we initiated our gigawatt hour scale manufacturing project to build a high-volume facility in the United States to meet the strong customer demand for our silicon nanowire anode battery technology. In September of this year, we closed our business combination with Kensington Capital, a critical step on our road map to build a scale that can help fulfill market demand. We could not have found a better partner than Kensington team. This transaction provides Amprius with access to the capital markets in addition to the proceeds raised today. That accelerate the development time line of our gigawatt hour scale manufacturing facility. Following the close, Kensington's Chairman and CEO, Justin Mirro, joined our Board. We are fortunate to continue working with Justin and be able to leverage the entire Kensington team's deeper expertise in automotive industry, as our long-term goal is to…

Thank you, Kang. I'd also like to thank our analysts and investors for joining us on this first earnings call. Our detailed financials can be found in our shareholder letter. I will spend a few minutes covering a few key topics. As Kang mentioned, we have a proprietary technology, proven manufacturability and commercial success, so we are focusing on scaling our production capacity to meet the growing demand in these fast-moving markets. In our financials, particularly in our revenue results, you will see data points that reinforce the strength of our customer development efforts as we scale. Those results, when paired with the investments in our Fremont capacity and gigawatt scale capabilities, we believe position the company well to achieve its growth and profitability potential. We closed out the third quarter of 2022 with $0.8 million in revenue. Product revenue was $0.5 million, including 9 customers sampled in total, including 2 leading eVTOL manufacturers. We delivered commercial quantity shipments to AeroVironment and Teledyne FLIR, and we shipped the ninth flight set to Airbus for their high-altitude pseudo-satellite program with a backlog of 6 more sets for future deliveries. Development services revenue was $0.3 million based on the delivery of cells and reports under contract with the U.S. Army for development of cells with gel electrolyte. For the third quarter of 2022, our GAAP gross profit margin was negative 180%. Variation in gross margin period-over-period is based on the mix of products and services. Moving now to our operating expense management. Our GAAP operating expense for the third quarter of 2022 was $2.9 million. Our Q3 GAAP net loss was $4.2 million or a loss of $0.06 per share. As of September 30, 2022, there were 54 full-time employees based in our Fremont, California location. Share-based compensation for the third quarter…

Thanks, Sandra. In September, Amprius entered public market, so we could better capitalize on the significant market growth for batteries in the aviation and the EV spaces. As a result of our demonstrated success with Airbus and other Tier 1 customers, we are becoming a market pioneer in providing high-performance batteries to the aviation industry through customer education, design wins and the recurring orders. We believe our strong market position will enable us to expand our presence in the rapidly growing aviation markets while also serving other mobility-related markets, including electrical vehicles that require improvements in their electrification solutions. To take advantage of the tremendous opportunity in this market, we must first build a high-volume manufacturing facility. Today, we have more customer inquiries than our capacity can serve, which is why we are diligently working towards expanding production at our current facility in Fremont, California and finalizing the location for our gigawatt-hour scale manufacturing facility, which we have layered on to Texas or Georgia. We are in discussion with the landlord and expect to allow a site by the end of 2022. In anticipation of our high production capacity, we are making significant progress in technology and product development as well as customer acquisitions. We have enhanced our battery's physical energy density from 450-watt hour per kilo to 500-watt hour per kilo. While this optimized design is still in its final development and the testing phase in our labs, we are decided to be developing the next generation of a superior battery performance for our current and future customers. Furthermore, we are pleased to announce that our 390-watt hour per kilo polymer electrolyte cell has successfully passed the military performance specification new penetration tests, which will be conducted and verified by independent third-party lab. This is another significant step in the development of our technology and product portfolio. The marked increase in energy density performance, combined with lower overall weight of the battery has the potential to be used in many applications, including wearable devices. We'll be providing additional details on this achievement in the upcoming press release as well as a video of the nail penetration test. Finally, on the commercial side, we are rapidly building the customer pipeline as our customers' product approaching commercial launch and our batteries are validated by more commercial applications. To summarize, Amprius continues to execute on its strategic growth plan of commercializing its proprietary silicon nanowire anode technology and capitalize on the robust market demand for next-generation batteries. Backed by our innovative products, strong balance sheet and grants, supportive base of customers and the team of technology innovators and experienced business operators, we believe Amprius is uniquely positioned to advance the future of electrical mobility today. The team at Amprius appreciates your continued support, and we look forward to what is ahead for our company and the battery industry. With that, we are ready to open the call for questions. Operator?

[Operator Instructions] Our first question comes from the line of Colin Rusch from Oppenheimer.

Kang, as you look at installing this new large-scale tool and going through the evaluation of the process, can you talk about just the cadence of activity that you're expecting to go through and some of the key milestones that we should be anticipating over the next several quarters?

Yes. We have this -- Colin, we just received this tool from centrotherm. This is a small scale of a large-scale manufacturing tool that give us approximately 2-megawatt capacity here. So why we need to have this first module in Fremont, California because we need that to test out the entire manufacturing process with this tool. We already -- we have done some tests at centrotherm this year. So this tool not only test the silicon nanowire growth, this enable us to test entire volume manufacturing protocol.

Fantastic. I'll follow up off line for some more detail. And then I guess that dovetails into my second question around customer qualification of both the product and the process. So obviously, you've been -- you're shipping revenue units to a number of companies or a number of customers. But as folks want to scale up with you guys, can you talk a little bit about the concurrent activity around qualification of the factory so that as you get the equipment installed in the new site and begin ramping, how prepared are those folks going to be taking product and having that product designed into their offerings out into the market?

Colin, as you know, we're already manufacturing activities since 2016. We started supplying customer commercial products since 2018 and the first customer was Airbus. So we have a robust manufacturing process already but at a small scale and a kilowatt-hour scale. This new tool will be available to start supplying customer prototypes and for the battery made on this new tool sometime in the third quarter next year.

Fantastic. And then the final one is for Sandra. As you evaluate the sources of capital that you have out there, it seems like you may have a couple of other potential grants that you could get or other elements that may be nondilutive. Can you talk a little bit about your ability to finalize the total capital structure with nondilutive financing?

So there are many programs out there. We were incredibly pleased and thank you for the Department of Energy grant to receive that $50 million. There are -- there's a DOE loan program. There are many other options that we're continuing to look at as we continually assess our capital needs in the longer term.

Our next question comes from the line of Chip Moore from EF Hutton.

I guess, first, congratulations to you and the team just for making it to your first public call. Wanted to ask in Fremont, back to the centrotherm equipment that you've got in now. So just getting to -- I think you said, Kang, prototypes sort of Q3 next year. Just help us, I guess, with that ramp, what you need to do in terms of tweaks and I think it was automation around handling the foil, but just kind of remind us what you need to get done once you get the equipment installed.

Yes. Chip, we have all the building blocks ready for this volume manufacturing process. What we need to do is a test and verify each technical building blocks, I mean the silicon growth and the back-end assembly activities and then integrate them together. That will require 2 or 3 quarters to finish that. So since we have been in manufacturing mode for over 4 years, so this basically is an integration job, okay, instead of innovation. So we already have, as I say, we have all the technical building blocks. We just need to put these together. Based on current plans, we should have this line running for prototyping some time in Q3 last year and started supplying small volumes. We have nameplate capacity 2-megawatt end of the 2023 or Q1 2024.

Got it. That's helpful. And just in terms of the pace of capital expenditures, obviously, you talked about higher CapEx, Sandra, moving forward. Can you help us with that pace, particularly given the cost sharing grant from the DOE, just how to think about at a high level CapEx?

So for the Fremont facility build-out, we think it will be a couple of million a quarter for the next couple of quarters. And then for the large-scale facility, we hope to be able to announce the site and lock it in by the end of the year, as Kang mentioned. And then we would start the design and construction phase -- design and planning phase in Q1 and likely construction in Q2 to keep us on the aggressive time line to try to have the production line qualified and running within 18 to 24 months.

Got it. Okay. So more significant CapEx in the back half of next year?

Right. As we said in the call -- go ahead.

No, go ahead.

The cost-sharing arrangement with the Department of Energy is still to be negotiated as far as the final allocation of cost against which part of the demonstration facility that we've committed to. So it's hard to know what will go to CapEx versus OpEx, but we expect that to cover a technical status, including design and resources as we move forward.

Understood. Okay. That's helpful. And maybe just the last one. Any updates on EV program, the battery consortium, just how those efforts are coming in terms of cycle life and some of those important metrics?

Yes. We are making progress here, Chip. This is a 2-year program. We just start in March. So we are making progress here. Hopefully, at our next call, we are going to report the progress of the program.

At this time, this concludes the company's question-and-answer session. If your question was not taken, you may contact Amprius Investor Relations team at ir@amprius.com. I now would like to turn the call back over to Dr. Sun for his closing remarks.

Thank you for joining us on today's call. I would like to thank our employees, partners and the shareholders for their continued support. As a reminder, you may learn more about our strategy in the investor presentation available in the Investor Relations section of our website. We look forward to updating you on Amprius progress on our next earnings call.

Ladies and gentlemen, thank you for joining us today. You may now disconnect your lines.